Drug Shortage Report for MIOCHOL-E
Report ID | 212474 |
Drug Identification Number | 02133326 |
Brand name | MIOCHOL-E |
Common or Proper name | MIOCHOL-E SOLN 20MG/2ML |
Company Name | BAUSCH & LOMB INC |
Market Status | MARKETED |
Active Ingredient(s) | ACETYLCHOLINE CHLORIDE |
Strength(s) | 20MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | OPHTHALMIC OPHTHALMIC |
Packaging size | 1 |
ATC code | S01EB |
ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2023-12-10 |
Actual start date | 2023-11-08 |
Estimated end date | 2024-05-05 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1400 N GOODMAN STREET ROCHESTER, NEW YORK UNITED STATES 14609 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-03-06 | French | Compare |
v6 | 2024-03-06 | English | Compare |
v5 | 2024-02-27 | French | Compare |
v4 | 2024-02-27 | English | Compare |
v3 | 2023-12-04 | French | Compare |
v2 | 2023-12-04 | English | Compare |
v1 | 2023-12-04 | English | Compare |
Showing 1 to 7 of 7